<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Adaptive Biotechnologies Corporation

    Adaptive Biotechnologies Corporation

    We are a commercial-stage biotech company focused on harnessing the inherent biolo...

    We are a commercial-stage biotech company focus...

    Filing Type:    PU
    Aptinyx Inc.

    Aptinyx Inc.

    Aptinyx Inc. is a clinical-stage biopharmaceutical company discovering and develop...

    Aptinyx Inc. is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Systec & Solutions GmbH

    Systec & Solutions GmbH

    Systec & Solutions GmbH, with headquarters in Karlsruhe (Germany), is a specialize...

    Systec & Solutions GmbH, with headquarters in K...

    Filing Type:    PR
    ENDRA Life Sciences Inc.

    ENDRA Life Sciences Inc.

    ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broade...

    ENDRA Life Sciences' mission is to bring new ca...

    Filing Type:    PU
    Insitu Biologics, Inc

    Insitu Biologics, Inc

    InSitu Biologics is an emerging biotech company focusing on development of AnestaG...

    InSitu Biologics is an emerging biotech company...

    Amount Raised:    $2,000,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    Mirati Therapeutics, Inc.

    Mirati Therapeutics, Inc.

    Mirati Therapeutics (NASDAQ: MRTX) is a San Diego-based clinical-stage biotechnolo...

    Mirati Therapeutics (NASDAQ: MRTX) is a San Die...

    Filing Type:    PU
    MorphoSys AG

    MorphoSys AG

    MorphoSys (FSE & NASDAQ: MOR) is a clinical-stage biopharmaceutical company dedica...

    MorphoSys (FSE & NASDAQ: MOR) is a clinical-sta...

    Filing Type:    PU
    Tenax Therapeutics, Inc.

    Tenax Therapeutics, Inc.

    Tenax Therapeutics is focused on developing and commercializing pharmaceutical pro...

    Tenax Therapeutics is focused on developing and...

    Filing Type:    PU
    Redhill Biopharma Ltd.

    Redhill Biopharma Ltd.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a special...

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv...

    Filing Type:    PU
    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the ...

    Moleculin Biotech, Inc. is a clinical stage pha...

    Filing Type:    PU
    Athenex, Inc.

    Athenex, Inc.

    Athenex is a global oncology focused biopharmaceutical company dedicated to the di...

    Athenex is a global oncology focused biopharmac...

    Filing Type:    PU
    Anchiano Therapeutics Ltd.

    Anchiano Therapeutics Ltd.

    We are Anchiano Therapeutics, a pivotal-stage biopharmaceutical company focused on...

    We are Anchiano Therapeutics, a pivotal-stage b...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.